IL15 and lymphoma: Most of the ongoing/recruiting early phase clinical trials of IL-15 based therapy in lymphoma patients are using IL-15 super agonists and in combination with other anticancer therapeutics due to the challenges with IL-15 monotherapy mentioned before.